Getagraph.com logo
S&P 500 Futures
(-0.40%) 5 193.00 points
Dow Jones Futures
(-0.17%) 38 961 points
Nasdaq Futures
(-0.59%) 18 093 points
Oil
(-1.33%) $77.34
Gas
(2.17%) $2.26
Gold
(0.00%) $2 324.10
Silver
(0.09%) $27.57
Platinum
(-0.96%) $978.90
USD/EUR
(0.10%) $0.930
USD/NOK
(0.34%) $10.94
USD/GBP
(0.25%) $0.801
USD/RUB
(0.75%) $92.13

リアルタイムの更新： Morepen Laboratories [MOREPENLAB.NS]

取引所: NSE セクター: Healthcare 産業: Drug Manufacturers—Specialty & Generic
Upcoming Earnings Alert

2 days till quarter result
(bmo 2024-05-10)

Expected move: +/- 5.21%

最終更新日時8 5月 2024 @ 19:00
25% discount on Stockinvest.us - Use code: Podcast

0.64% INR 46.90

Live Chart Being Loaded With Signals

Commentary (8 5月 2024 @ 19:00):

Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), branded and generic formulations, and home health products in India...

Stats
本日の出来高 1.64M
平均出来高 4.42M
時価総額 23.97B
EPS INR0 ( 2024-04-12 )
次の収益日 ( INR0 ) 2024-05-10
Last Dividend INR0.600 ( 2002-09-18 )
Next Dividend INR0 ( N/A )
P/E 31.27
ATR14 INR0.0660 (0.14%)

ボリューム 相関

長: -0.05 (neutral)
短: -0.79 (moderate negative)
Signal:(49.059) Neutral

Morepen Laboratories 相関

10 最も正の相関
10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Morepen Laboratories 相関 - 通貨/商品

The country flag 0.65
( weak )
The country flag 0.72
( moderate )
The country flag 0.00
( neutral )
The country flag 0.46
( neutral )
The country flag -0.56
( weak negative )
The country flag 0.08
( neutral )

Morepen Laboratories 財務諸表

Annual 2022
収益: INR14.18B
総利益: INR4.62B (32.58 %)
EPS: INR0.770
FY 2022
収益: INR14.18B
総利益: INR4.62B (32.58 %)
EPS: INR0.770
FY 2022
収益: INR15.42B
総利益: INR4.81B (31.18 %)
EPS: INR2.26
FY 2021
収益: INR11.75B
総利益: INR3.89B (33.06 %)
EPS: INR2.16

Financial Reports:

No articles found.

Morepen Laboratories Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A)

Morepen Laboratories Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 2.95 - low (50.00%) | Divividend Growth Potential Score: 3.53 - No dividend growth expected in the near future
Information
First Dividend INR0.600 2000-04-28
Last Dividend INR0.600 2002-09-18
Next Dividend INR0 N/A
Payout Date 2002-10-08
Next Payout Date N/A
# dividends 5 --
Total Paid Out INR2.00 --
Avg. Dividend % Per Year 0.00% --
Score 1.52 --
Div. Sustainability Score 2.95
Div.Growth Potential Score 3.53
Div. Directional Score 3.24 --
Next Divdend (Est)
 (2024-07-15)
INR0 Estimate 0.00 %
Dividend Stability
0.01 Very Bad
Dividend Score
1.52
Pay Frequency
Annually
Yearly Payout
Year Amount Yield
2000 INR0 0.00%
2001 INR0 0.00%
2002 INR0 0.00%
2003 INR0 0.00%
2004 INR0 0.00%
2005 INR0 0.00%
2006 INR0 0.00%
2007 INR0 0.00%
2008 INR0 0.00%
2009 INR0 0.00%
2010 INR0 0.00%
2011 INR0 0.00%
2012 INR0 0.00%
2013 INR0 0.00%
2014 INR0 0.00%
2015 INR0 0.00%
2016 INR0 0.00%
2017 INR0 0.00%
2018 INR0 0.00%
2019 INR0 0.00%
2020 INR0 0.00%
2021 INR0 0.00%
2022 INR0 0.00%
2023 INR0 0.00%
2024 INR0 0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
REDINGTON.NS Dividend Knight 2023-07-06 Annually 18 3.28%
KPITTECH.NS Dividend Knight 2023-08-14 Annually 6 0.47%
FACT.NS Dividend Junior 2023-09-22 Insufficient data to determine frequency 2 0.09%
AMRUTANJAN.NS Dividend Knight 2023-09-14 Semi-Annually 15 0.38%
TASTYBITE.NS Dividend Junior 2023-07-14 Annually 8 0.01%
NH.NS Dividend Junior 2023-07-06 Sporadic 6 0.14%
IMPAL.NS Dividend Junior 2023-07-20 Annually 19 1.79%
CHEVIOT.NS Dividend Junior 2023-08-03 Annually 3 1.62%
SALASAR.NS Dividend Junior 2023-09-15 Annually 8 1.41%
LUPIN.NS Dividend Junior 2023-07-14 Annually 23 0.37%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.04671.5009.0710.00[0 - 0.5]
returnOnAssetsTTM01.20000[0 - 0.3]
returnOnEquityTTM0.09881.500-0.0137-0.0206[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM00.800-5.00-4.00[1 - 3]
quickRatioTTM00.800-4.71-3.76[0.8 - 2.5]
cashRatioTTM01.500-1.111-1.667[0.2 - 2]
debtRatioTTM0-1.50000[0 - 0.6]
interestCoverageTTM31.041.00010.0010.00[3 - 30]
operatingCashFlowPerShareTTM1.2062.009.6010.00[0 - 30]
freeCashFlowPerShareTTM1.2062.009.4010.00[0 - 20]
debtEquityRatioTTM0-1.50000[0 - 2.5]
grossProfitMarginTTM0.3591.0007.367.36[0.2 - 0.8]
operatingProfitMarginTTM0.06611.000-0.678-0.678[0.1 - 0.6]
cashFlowToDebtRatioTTM01.000-1.111-1.111[0.2 - 2]
assetTurnoverTTM00.800-3.33-2.67[0.5 - 2]
Total Score2.95

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM31.661.0006.900[1 - 100]
returnOnEquityTTM0.09882.50-0.00883-0.0206[0.1 - 1.5]
freeCashFlowPerShareTTM1.2062.009.6010.00[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM1.2062.009.6010.00[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM6.841.50010.000[0.5 - 2]
operatingCashFlowSalesRatioTTM0.03781.000-1.5550[0.1 - 0.5]
Total Score3.53

Morepen Laboratories

Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), branded and generic formulations, and home health products in India. The company offers APIs for anti-histaminic, anti-asthmatic, anti-hypercholesterolemic, anti-hypertensive, and anti-diabetic drugs; point of care and medical devices; and home diagnostic products, such as air purifiers, thermometers, stethoscopes, blood pressure monitors, pulse-oximeters, nebulizers, glucometers, strips, sanitizers, disinfectant solutions, masks and gloves, and others. It also provides Burnol, a burn cream; Lemolate for cough and cold; and Fiber-X, a sat isabgol; and formulations for gastro, antibiotics, vitamins, nutritional, and anti-diabetics, as well as cardiac. In addition, the company is involved in the product contract manufacturing and brand sharing businesses; and provision of over-the-counter products under the Dr. Morepen brand. It exports its products to approximately 75 countries. Morepen Laboratories Limited was incorporated in 1984 and is based in New Delhi, India.

について ライブシグナル

このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。